{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:28:02Z","timestamp":1767148082760,"version":"build-2238731810"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["10047831"],"award-info":[{"award-number":["10047831"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003662","name":"Korea Evaluation Institute of Industrial Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002632","name":"Hallym University","doi-asserted-by":"publisher","award":["HURF-2018-38"],"award-info":[{"award-number":["HURF-2018-38"]}],"id":[{"id":"10.13039\/501100002632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.prp.2019.152671","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T11:30:35Z","timestamp":1569583835000},"page":"152671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis"],"prefix":"10.1016","volume":"215","author":[{"given":"Kyueng-Whan","family":"Min","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Young","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Suk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Sook","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Rim","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Kee","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.152671_bib0005","series-title":"SEER Cancer Stat Facts: Melanoma of the Skin","year":"2016"},{"key":"10.1016\/j.prp.2019.152671_bib0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4132\/KoreanJPathol.2013.47.4.348","article-title":"Comparison of three BRAF mutation tests in formalin-fixed paraffin embedded clinical samples","volume":"47","author":"Ahn","year":"2013","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.prp.2019.152671_bib0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2012.03.005","article-title":"Assessment of BRAF and KIT mutations in Japanese melanoma patients","volume":"66","author":"Ashida","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.prp.2019.152671_bib0020","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2019.152671_bib0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/ng1586","article-title":"Use of human tissue to assess the oncogenic activity of melanoma-associated mutations","volume":"37","author":"Chudnovsky","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2019.152671_bib0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2019.152671_bib0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4065\/81.4.500","article-title":"Cutaneous malignant melanoma","volume":"81","author":"Cummins","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.prp.2019.152671_bib0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.prp.2019.152671_bib0045","first-page":"139","article-title":"The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites","volume":"29","author":"Deichmann","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2019.152671_bib0050","first-page":"11","article-title":"Targeting RAS signalling pathways in cancer therapy, Nature reviews","volume":"3","author":"Downward","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2019.152671_bib0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","article-title":"Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma","volume":"72","author":"Erdag","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2019.152671_bib0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/CMR.0000000000000278","article-title":"BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study","volume":"26","author":"Frank","year":"2016","journal-title":"Melanoma Res."},{"key":"10.1016\/j.prp.2019.152671_bib0065","series-title":"American Joint Committe on Cancer (AJCC) Cancer Staging Manual","first-page":"563","article-title":"Melanoma of the skin","author":"Gershenwald","year":"2016"},{"key":"10.1016\/j.prp.2019.152671_bib0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.jid.5700026","article-title":"Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma","volume":"126","author":"Goel","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2019.152671_bib0075","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jamcollsurg.2004.10.032","article-title":"Detection of B-RAF and N-RAS mutations in human melanoma","volume":"200","author":"Goydos","year":"2005","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.prp.2019.152671_bib0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5021\/ad.2014.26.2.195","article-title":"Prognostic and clinicopathologic associations of BRAF mutation in primary acral lentiginous melanoma in korean patients: a preliminary study","volume":"26","author":"Hong","year":"2014","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.prp.2019.152671_bib0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/ajco.12574","article-title":"A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan","volume":"12","author":"Huang","year":"2016","journal-title":"Asia. J. Clin. Oncol."},{"key":"10.1016\/j.prp.2019.152671_bib0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12253-016-0121-2","article-title":"Mutation profile of B-Raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients","volume":"23","author":"Ide","year":"2017","journal-title":"Pathol. Oncol. Res.: POR"},{"key":"10.1016\/j.prp.2019.152671_bib0095","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3346\/jkms.2010.25.6.924","article-title":"Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006","volume":"25","author":"Kim","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.prp.2019.152671_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2015.02.1113","article-title":"Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma","volume":"72","author":"Kim","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.prp.2019.152671_bib0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.prp.2017.01.004","article-title":"Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers","volume":"213","author":"Kwon","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2019.152671_bib0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.humpath.2015.11.009","article-title":"Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value","volume":"50","author":"Kwon","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2019.152671_bib0115","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.prp.2017.02.015","article-title":"Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas","volume":"213","author":"Kwon","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2019.152671_bib0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.humpath.2018.03.025","article-title":"Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition","volume":"80","author":"Kwon","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2019.152671_bib0125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4132\/KoreanJPathol.2012.46.3.246","article-title":"Frequency of BRAF mutation and clinical relevance for primary melanomas","volume":"46","author":"Lee","year":"2012","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.prp.2019.152671_bib0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11912-012-0257-5","article-title":"Tumor-infiltrating lymphocytes in melanoma","volume":"14","author":"Lee","year":"2012","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.prp.2019.152671_bib0135","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4143\/crt.2017.535","article-title":"Genetic alterations among korean melanoma patients showing tumor heterogeneity: a comparison between primary tumors and corresponding metastatic lesions","volume":"50","author":"Lee","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.prp.2019.152671_bib0140","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4161\/cc.4.10.2026","article-title":"Analysis of BRAF mutation in primary and metastatic melanoma","volume":"4","author":"Libra","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2019.152671_bib0145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/pin.12215","article-title":"Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1","volume":"64","author":"Liu","year":"2014","journal-title":"Pathol. Int."},{"key":"10.1016\/j.prp.2019.152671_bib0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/jid.2012.283","article-title":"BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma","volume":"133","author":"Mann","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2019.152671_bib0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2017.03.012","article-title":"Baseline beta-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients","volume":"78","author":"Massi","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2019.152671_bib0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/CMR.0b013e328353e673","article-title":"Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma","volume":"22","author":"McClain","year":"2012","journal-title":"Melanoma Res."},{"key":"10.1016\/j.prp.2019.152671_bib0165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4143\/crt.2017.166","article-title":"Nationwide trends in the incidence of melanoma and non-melanoma skin cancers from 1999 to 2014 in South Korea","volume":"50","author":"Oh","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.prp.2019.152671_bib0170","first-page":"6483","article-title":"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression","volume":"9","author":"Omholt","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2019.152671_bib0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.prp.2019.152671_bib0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.cmr.0000222600.73179.f3","article-title":"BRAF and NRAS mutations in melanoma and melanocytic nevi","volume":"16","author":"Poynter","year":"2006","journal-title":"Melanoma Res."},{"key":"10.1016\/j.prp.2019.152671_bib0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.11722","article-title":"Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas","volume":"109","author":"Reifenberger","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2019.152671_bib0190","first-page":"134","article-title":"Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients","volume":"7","author":"Roh","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2019.152671_bib0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jdermsci.2015.07.012","article-title":"Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients","volume":"80","author":"Sakaizawa","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.prp.2019.152671_bib0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/jid.2011.305","article-title":"Review and cross-validation of gene expression signatures and melanoma prognosis","volume":"132","author":"Schramm","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2019.152671_bib0205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000362788","article-title":"Malignant melanoma with concurrent BRAF E586K and NRAS Q81K mutations","volume":"7","author":"Shackelford","year":"2014","journal-title":"Case Rep. Oncol."},{"key":"10.1016\/j.prp.2019.152671_bib0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jfma.2015.02.001","article-title":"Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan","volume":"115","author":"Sheen","year":"2016","journal-title":"J. Formosan Med. Assoc. = Taiwan yi zhi"},{"key":"10.1016\/j.prp.2019.152671_bib0215","first-page":"121","article-title":"ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development","volume":"5","author":"Shukla","year":"1989","journal-title":"Oncogene Res."},{"key":"10.1016\/j.prp.2019.152671_bib0220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2011.06.056","article-title":"Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort","volume":"48","author":"Si","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2019.152671_bib0225","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00262-014-1545-8","article-title":"Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma","volume":"63","author":"Simeone","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.prp.2019.152671_bib0230","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.0022-202X.2005.23812.x","article-title":"Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas","volume":"125","author":"Takata","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2019.152671_bib0235","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1200\/JCO.2013.51.3002","article-title":"Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study","volume":"31","author":"Thomas","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2019.152671_bib0240","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/DAD.0000000000000241","article-title":"Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma","volume":"37","author":"Yaman","year":"2015","journal-title":"Am. J. Dermatopathol."}],"updated-by":[{"DOI":"10.1016\/j.prp.2020.153316","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819315481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819315481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:36:20Z","timestamp":1762295780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819315481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0344033819315481"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152671","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152671"}}